Electrogram Guided Myocardial Advanced Phenotyping (EMAP) Study for patients recently diagnosed with cardiomyopathy
This study is enrolling newly diagnosed heart failure (within 6 months from diagnosis) patients with no known cause for their heart disease. We are utilizing already used technology, voltage mapping capabilities used in electrophysiology procedures, to more directly target weaker areas of the left and right ventricles. our physicians would biopsy the places the mapping technology guides us, and our goal is to understand the potential benefit in yield of this technique.
- Study Identifier: 826102
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required